GSK - TREATMENT WAS GENERALLY WELL TOLERATED WITH NO SERIOUS ADVERSE EVENTS IDENTIFIED
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Gsk - Treatment Was Generally Well Tolerated With No Serious Adv…
GSK - TREATMENT WAS GENERALLY WELL TOLERATED WITH NO SERIOUS ADVERSE EVENTS IDENTIFIED